Grant of cell therapy membrane patents
The UK patent office has issued the Kalyptix® patent (GB1914184.5) covering an immune-protective bilayer membrane. We use the Kalyptix technology platform to create implantable devices for cell therapy which act as a barrier to cells yet permit diffusion of molecules such as glucose and insulin. In addition, the European patent office has issued the microscaffold… Read more »
Virtual Cell and Gene Meeting on the Mesa, 19-20 Oct
We are attending the virtual Cell and Gene Meeting on the Mesa 2021 from 12th to 14th October 2021. Ann Kramer, our CEO, will be attending the event virtually and will be available for 1×1 partnering meeting on October 19-20. Contact us prior to the event to set up a meeting. The Cell and Gene… Read more »
Setting Standards for Synthetic Biomaterials
The ASTM International defines and sets global standards across industries; these standards are used to improve product quality, enhance health and safety, strengthen market access, and trade, and build consumer confidence. Standardisation is an important factor in the medical field and being a part of this committee gives us the platform to influence and help… Read more »
Webinar: Cell Therapies: Bench to Bedside, 1 April
Medilink are partnering with Medical Technologies Innovation Facility (MTIF) to present a Cell Therapy Webinar titled “Cell Therapies: Bench to Bedside” on Thursday 1st April 2021 from 10am, BST. Our CEO, Ann Kramer will be presenting as a speaker in this event. Her talk is titled: “Cell Therapy: Bench to Bedside: A biomaterials case study”…. Read more »
Cell Therapy Blog: In conversation with Professor John Hunt
We are joined by Professor John Hunt, Research Theme lead for Medical Technologies and Advanced Materials at Nottingham Trent University and the academic lead for the Medical Technologies Innovation Facility (MTIF). John has over 3 decades of experience developing breakthrough therapies, devices and technology to repair, replace, augment and in the future regenerate diseased, infected… Read more »
Bringing Biomaterials to the Fore in Cell Therapy
Reading Time ~ 8 minutes Despite the success of cell therapies in some areas, such as CAR-T cells for lymphomas, translation to the clinic has generally been much less rapid and impactful than originally anticipated. One of the reasons for this may be that most of the attention has been focused on the cells themselves… Read more »
Advanced Therapies Connect, 26-27 Jan 2021
We will be attending the Advanced Therapies Connect 2021 held virtually on the 26-27th January 2021. Advanced Therapies Connect is a platform for biotechs to build relationships and partnerships with the mission to help Biotechs progress along their commercialisation journey. Ann Kramer, our CEO will be attending the events and will be available to discuss… Read more »
Microscaffold Patent Granted
On 23 June 2020, the UK patent office issued the Microscaffold patent (GB2544748A). Our custom Microscaffolds can be made from a large variety of materials and sizes, tailored towards their desired application. Their open, porous, three-dimensional structure allows for facile cell attachment and integration over a large range of cell types. These scaffolds can form… Read more »
Virtual Advanced Therapies Connect – 29-30 Sept
We will be attending the Advanced Therapies Connect 2020 held virtually on the 29th to 30th September 2020. Advanced Therapies Connect is a platform for biotechs to build relationships and partnerships with the mission to help Biotechs progress along their commercialisation journey. Ann Kramer will be attending session and will be available for meetings throughout… Read more »
